Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma
Fury, Matthew G., Xiao, Han, Sherman, Eric J., Baxi, Shrujal, Smith-Marrone, Stephanie, Schupak, Karen, Gewanter, Richard, Gelblum, Daphna, Haque, Sofia, Schoder, Heiko, Shah, Jatin P., Katabi, Nora,Том:
38
Мова:
english
Журнал:
Head & Neck
DOI:
10.1002/hed.24041
Date:
April, 2016
Файл:
PDF, 198 KB
english, 2016
File converter
Більше результатів пошуку
More benefits 
